Peripheral T-cell Lymphoma  >>  epirubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT05075460: Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma

Recruiting
3
107
RoW
Tucidinostat, Azacitidine combined with CHOP
Peking Union Medical College Hospital
T-cell Lymphoma
05/24
10/24
NCT05678933: AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH

Enrolling by invitation
3
200
RoW
Azacitidine, Chidamide, Cyclophosphamide, Epirubicin, Vincristine, Prednisone
Tianjin Medical University Cancer Institute and Hospital
Peripheral T-cell Lymphoma Targeted Therapy
12/27
12/29

Download Options